Literature DB >> 9454894

Polymerase chain reaction amplification of long DNA targets: application to analysis of chromosomal translocations in human B-cell tumors (review).

T Akasaka1, H Akasaka, H Ohno.   

Abstract

Chromosomal translocations in human leukemias generate fusion transcripts containing messages from two genes involved in the translocation, and these have been the targets for reverse transcriptase-mediated polymerase chain reaction (PCR). In contrast, many of the translocations in B-cell tumors involve immunoglobulin gene (IG) loci, and coding regions of the oncogenes on partner chromosomes are not interrupted by the translocation. Therefore, targets for PCR amplification are single-copy oncogene/IG fusion sequences within the complex genomic DNA. We present here a novel strategy for detection of translocations in B-cell tumors on the basis of long-distance (LD-) PCR that is capable of amplifying up to 30 kb of DNA. LD-PCR is a general method using primer pairs designed for distinctive regions of IG and oncogenes involved in translocations, and amplifying long DNA fragments encompassing the oncogene/IG junction. LD-PCR is capable of detecting virtually all the important translocations in B-cell tumors, including t(8;14)(q24;q32), t(14;18)(q32;q21), t(3;14)(q27;q32) and its variants. We show here that LD-PCR can substitute for time-consuming Southern blot hybridization in the rapid detection of these translocations. Furthermore, as amplified fragments obtained by LD-PCR contained exons and flanking sequences of the oncogenes and IGs, restriction analysis and nucleotide sequencing of the products refined the characteristics of translocations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454894     DOI: 10.3892/ijo.12.1.113

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology.

Authors:  Xavier Sagaert; Thomas Tousseyn; Rhonda K Yantiss
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

2.  Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Authors:  Fumiyo Maekawa; Chiyuki Kishimori; Miho Nakagawa; Kayo Takeoka; Katsuhiro Fukutsuka; Masahiko Hayashida; Futoshi Iioka; Masakazu Fujimoto; Kengo Takeuchi; Hirokazu Nakamine; Hitoshi Ohno
Journal:  Blood Adv       Date:  2021-01-12

3.  Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2V617F-myeloproliferative neoplasm.

Authors:  Katsuhiro Fukutsuka; Futoshi Iioka; Fumiyo Maekawa; Miho Nakagawa; Chiyuki Kishimori; Masahiko Hayashida; Shunsuke Tagawa; Takashi Akasaka; Gen Honjo; Hitoshi Ohno
Journal:  J Clin Exp Hematop       Date:  2021-05-14

4.  Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.

Authors:  N Yonetani; C Ueda; T Akasaka; M Nishikori; T Uchiyama; H Ohno
Journal:  Jpn J Cancer Res       Date:  2001-09

5.  t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.

Authors:  Hitoshi Ohno; Kayo Takeoka; Chiyuki Kishimori; Miho Nakagawa; Katsuhiro Fukutsuka; Fumiyo Maekawa; Masahiko Hayashida; Takashi Akasaka; Shinji Sumiyoshi
Journal:  J Clin Exp Hematop       Date:  2021-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.